Cargando…

Systematic design and comparison of expanded carrier screening panels

PURPOSE: The recent growth in pan-ethnic expanded carrier screening (ECS) has raised questions about how such panels might be designed and evaluated systematically. Design principles for ECS panels might improve clinical detection of at-risk couples and facilitate objective discussions of panel choi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beauchamp, Kyle A, Muzzey, Dale, Wong, Kenny K, Hogan, Gregory J, Karimi, Kambiz, Candille, Sophie I, Mehta, Nikita, Mar-Heyming, Rebecca, Kaseniit, K Eerik, Kang, H Peter, Evans, Eric A, Goldberg, James D, Lazarin, Gabriel A, Haque, Imran S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763154/ https://www.ncbi.nlm.nih.gov/pubmed/28640244 http://dx.doi.org/10.1038/gim.2017.69

Ejemplares similares

Inter‐lab concordance of variant classifications establishes clinical validity of expanded carrier screening
por: Kaseniit, Kristjan E., et al.
Publicado: (2019)

Genetic ancestry analysis on >93,000 individuals undergoing expanded carrier screening reveals limitations of ethnicity-based medical guidelines
por: Kaseniit, Kristjan E., et al.
Publicado: (2020)

Clinical utility of expanded carrier screening: results-guided actionability and outcomes
por: Johansen Taber, Katherine A., et al.
Publicado: (2018)

The impact of HBB‐related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening
por: Putra, Manesha, et al.
Publicado: (2022)

Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples
por: Ghiossi, Caroline E., et al.
Publicado: (2017)

A data-driven evaluation of the size and content of expanded carrier screening panels
por: Ben-Shachar, Rotem, et al.
Publicado: (2019)

Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels
por: Lazarin, Gabriel A., et al.
Publicado: (2014)

Strategies to minimize false positives and interpret novel microdeletions based on maternal copy-number variants in 87,000 noninvasive prenatal screens
por: Kaseniit, Kristjan Eerik, et al.
Publicado: (2018)

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen
por: Beauchamp, Kyle A., et al.
Publicado: (2019)

Clinical validity of expanded carrier screening: Evaluating the gene‐disease relationship in more than 200 conditions
por: Balzotti, Marie, et al.
Publicado: (2020)

Screening for Tay‐Sachs disease carriers by full‐exon sequencing with novel variant interpretation outperforms enzyme testing in a pan‐ethnic cohort
por: Cecchi, Alana C., et al.
Publicado: (2019)

Smith–Lemli–Opitz syndrome carrier frequency and estimates of in utero mortality rates
por: Lazarin, Gabriel A., et al.
Publicado: (2017)

Evaluating the efficacy of three carrier screening workflows designed to identify at‐risk carrier couples
por: Arjunan, Aishwarya, et al.
Publicado: (2021)

Evaluation and classification of severity for 176 genes on an expanded carrier screening panel
por: Arjunan, Aishwarya, et al.
Publicado: (2020)

Sequencing as a first-line methodology for cystic fibrosis carrier screening
por: Beauchamp, Kyle A., et al.
Publicado: (2019)

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
por: Vysotskaia, Valentina, et al.
Publicado: (2019)

Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening
por: Beauchamp, Kyle A., et al.
Publicado: (2019)

Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population
por: Mehta, Nikita, et al.
Publicado: (2016)

Genetic Counselors’ Perspectives and Practices Regarding Expanded Carrier Screening after Initial Clinical Availability
por: Lazarin, Gabriel A., et al.
Publicado: (2016)

Changing trends in carrier screening for genetic disease in the United States
por: Nazareth, Shivani B., et al.
Publicado: (2015)

Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
por: Dolitsky, Shelley, et al.
Publicado: (2020)

Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management
por: Arjunan, Aishwarya, et al.
Publicado: (2020)

Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk
por: Muzzey, Dale, et al.
Publicado: (2019)

An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals
por: Lazarin, Gabriel A., et al.
Publicado: (2013)

Response to “Noninvasive prenatal screening at low fetal fraction: comparing whole‐genome sequencing and single‐nucleotide polymorphism methods”
por: Muzzey, Dale, et al.
Publicado: (2017)

Response to Stoll and Resta
por: Lazarin, Gabriel A., et al.
Publicado: (2013)

Responsible implementation of expanded carrier screening
por: Henneman, Lidewij, et al.
Publicado: (2016)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
por: Kang, Hyunseok P., et al.
Publicado: (2016)

The evolving landscape of expanded carrier screening: challenges and opportunities
por: Kraft, Stephanie A., et al.
Publicado: (2018)

Understanding the Basics of NGS: From Mechanism to Variant Calling
por: Muzzey, Dale, et al.
Publicado: (2015)

The Expanding Spectrum of Dystrophinopathies: HyperCKemia to Manifest Female Carriers
por: Suthar, Renu, et al.
Publicado: (2021)

Expanded carrier screening in gamete donors of Venezuela
por: Urbina, Maria Teresa, et al.
Publicado: (2017)

The use of expanded carrier screening of gamete donors
por: Payne, Molly R, et al.
Publicado: (2021)

Extensive and coordinated control of allele-specific expression by both transcription and translation in Candida albicans
por: Muzzey, Dale, et al.
Publicado: (2014)

Clinical experience with multigene carrier panels in the reproductive setting
por: Terhaar, Catherine, et al.
Publicado: (2018)

Expanding the Pathogen Panel in Wastewater Epidemiology to Influenza and Norovirus
por: Markt, Rudolf, et al.
Publicado: (2023)

High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains
por: Philip, V M, et al.
Publicado: (2010)

A case for expanding carrier testing to include actionable X‐linked disorders
por: Rope, Alan F., et al.
Publicado: (2018)

Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening
por: Clarke, Elizabeth V., et al.
Publicado: (2018)

Societal implications of expanded universal carrier screening: a scoping review
por: van den Heuvel, Lieke M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jakjmbvopsm8iqv8um70a19que